mediastinal malignant lymphoma
mediastinal malignant lymphoma
Explore linked clinical trials. Standard reference: MONDO:00040216 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab 40 mg in Combination With Chemo-Immunotherapy for Newly Diagnosed Primary Mediastinal B-Cell Lymphoma | mediastinal malignant lymphoma | Active, not recruiting | Phase 3 | 2026-10-08 | NCT06188676 | |
| Proton Therapy for Mediastinal Lymphoma (PROMLY) | B-cell neoplasm, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mediastinal malignant lymphoma, neoplasm | Recruiting | Not applicable | 2026-09-14 | NCT07817641 | |
| Registry Study of Proton Radiotherapy in Lymphoma | mediastinal malignant lymphoma | Recruiting | Not stated | 2026-04-29 | NCT04613388 | |
| CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, diffuse large B-cell lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mediastinal malignant lymphoma, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-02 | NCT04787263 | |
| Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, immune system disorder, immunoproliferative disorder, injury, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mediastinal malignant lymphoma, neoplasm, non-Hodgkin lymphoma, radiation injury | Not yet recruiting | Not stated | 2023-04-18 | NCT03969693 | |
| B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mediastinal malignant lymphoma, neoplasm, primary central nervous system lymphoma, viral infectious disease | Recruiting | Phase 4 | 2022-08-26 | NCT05518383 |